PMVP
Pmv Pharmaceuticals Inc
NASDAQ: PMVP · HEALTHCARE · BIOTECHNOLOGY
$1.39
-2.11% today
Updated 2026-04-29
Market cap
$74.13M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.48
Dividend yield
—
52W range
$1 – $2
Volume
0.7M
Pmv Pharmaceuticals Inc (PMVP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-55.40%
ROA
-35.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-17.54M | — | — | — |
| 2019 | $0.00 | $-25.35M | — | — | — |
| 2020 | $0.00 | $-34.44M | — | — | — |
| 2021 | $0.00 | $-57.85M | — | — | — |
| 2022 | $0.00 | $-73.32M | — | — | — |
| 2023 | $0.00 | $-68.96M | — | — | — |
| 2024 | $0.00 | $-58.71M | — | — | — |
| 2025 | $0.00 | $-77.74M | — | — | — |